-
Product Insights
NewNeuronetics Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Neuronetics Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Neuronetics Inc (Neuronetics) is a medical technology company that develops non-invasive therapies for psychiatric and neurological disorders. In addition, Neuronetics also offers services such as clinical training, patient education, reimbursement support, and practice support. The company conducts research and clinical trials for the clinical drugs. The company offers NeuroStar which is an unique form of TMS which helps patients in...
-
Product Insights
NewQuarterly Condiment Sauces pricing trends in Ukraine
Empower your strategies with our Quarterly Condiment Sauces pricing trends in Ukraine report and make more profitable business decisions. Consumers’ preferences for stores are most heavily influenced by pricing and promotions, but brands and retailers continue to adjust prices and promotions based on insufficient information from expensive, drawn-out, and incomplete audits of rival techniques. Brands and retailers can benefit from the unique intelligence provided by GlobalData Ecommerce Price Tracker, covering millions of SKUs, to identify, anticipate, and implement important business...
-
Product Insights
TM 2 Mine
The TM 2 Mine is a coal mine in United States. It is currently in operation. Empower your strategies with our TM 2 Mine report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons to buy...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BMS-986218 in Melanoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BMS-986218 in Melanoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BMS-986218 in Melanoma Drug Details: BMS-986218 is under development for the treatment of...
-
Product Insights
TM Invest Niksic Solar PV Park
TM Invest Niksic Solar PV Park is a solar PV project located in Niksic, Montenegro. The project is expected to come online in 2026. Empower your strategies with our TM Invest Niksic Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Q-Cells in Transverse Myelitis (TM)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Q-Cells in Transverse Myelitis (TM) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Q-Cells in Transverse Myelitis (TM) Drug Details: Q-Cells is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TMS-007 in Acute Ischemic Stroke
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.TMS-007 in Acute Ischemic StrokeDrug Details:TMS-007 (Stachybotrys microspora triprenyl phenol-7) is under development for the treatment...
-
Product Insights
NewCancer Anorexia-Cachexia Syndrome – Drugs In Development, 2024
Empower your strategies with our Cancer Anorexia-Cachexia Syndrome – Drugs In Development, 2024 report and make more profitable business decisions. Cancer anorexia-cachexia syndrome is defined as progressive weight loss associated with malignancy and is characterized by loss of appetite (anorexia), skeletal muscle wasting, and reduced adipose tissue. Approximately 50% of cancer patients report abnormalities of eating behavior at the time of first diagnosis and prevalence is even higher at approximately 65%. The incidence of weight loss upon diagnosis varies greatly according...
-
Product Insights
NewAcute Renal Failure (ARF) (Acute Kidney Injury) – Drugs In Development, 2024
Empower your strategies with our Acute Renal Failure (ARF) (Acute Kidney Injury) – Drugs In Development, 2024 report and make more profitable business decisions. Acute renal failure occurs when the kidneys suddenly become unable to filter waste products from blood. Symptoms include drowsiness, shortness of breath, fatigue, seizures or coma in severe cases, and chest pain. The predisposing factors include age, diabetes, high blood pressure, heart failure, and kidney diseases. Treatment includes antibiotics and diuretics. The Acute Renal Failure (ARF) (Acute...